What makes Pharma different.
Pharma spans clinical data management, drug development, manufacturing execution, and regulatory submission — each with distinct compliance obligations.
Pharma programs fail when FDA submission requirements are treated as documentation, not architecture constraints. MAXION captures clinical, regulatory, manufacturing, and IT simultaneously.
Every phase. Industry constraints built in.
Requirements capture across clinical, regulatory, and IT
Clinical, regulatory affairs, manufacturing, quality, and IT — each governed by different frameworks. Data governance and validation requirements surfaced.
Architecture with hard GxP constraints
FDA 21 CFR Part 11, GxP, and ICH E6 as active constraints. Audit trail requirements embedded from the start.
Implementation in your validated environment
Workspaces map to your validated repos and systems. Execute runs clinical data pipelines, validation protocols, and submission connectors — supervised, with every change traceable back to architecture.
What we typically run for Pharma clients.
Clinical Data Management Platform
Clinical data satisfying FDA 21 CFR Part 11 and GxP by design — discovered from clinical, regulatory, and IT simultaneously.
Related transformation programs for Pharma & Life Sciences
Cloud Migration & Modernisation
89% of well-scoped cloud programs succeed. The risk isn't the cloud — it's the scoping.
Compliance & Security Transformation
Compliance requirements are treated as constraints in APEX — not as checklist items added after architecture decisions are made.
Data Management & Analytics
85% of data lakes fail to deliver value. The root cause is always the same: built around what the data team wanted to build, not what business users need to decide.
Your Pharma program has specific requirements. So does your pilot.
Tell us about your sector and your regulatory environment — whether you're running the transformation, selling it, or delivering it. We'll scope a pilot that fits.